Inventor · disambiguated record
Ferdinand Bahlmann
Also filed as: BAHLMANN FERDINAND · BAHLMANN FERDINAND H · BAHLMANN FERDINAND HERMANN
2 granted patents·7 pending applications·9 citations·filing 2003–2014
55Inventor score
Files withEPOPLUS GMBH & CO KG4LOPHIUS BIOSCIENCES GMBH2BAHLMANN FERDINAND H1BAHLMANN FERDINAND HERMANN1RED FLAG DIAGNOSTICS GMBH1
Top patents by PatentIndex Score
9 records- 0167US7745387B2Use of erythropoietinEPOPLUS GMBH & CO KG·Filed 2003·Granted Jun 29, 2010·8 cites·7 claims
- 0257US9476877B2In-vitro process for the quick determination of a patient's status relating to infection with Mycobacterium tuberculosisLOPHIUS BIOSCIENCES GMBH·Filed 2014·Granted Oct 25, 2016·1 cites·19 claims
- 0340US2010247451A1Use of erythropoietinEPOPLUS GMBH & CO KG·Filed 2010·Application pending·0 cites
- 0440US2010247452A1Use of erythropoietinEPOPLUS GMBH & CO KG·Filed 2010·Application pending·0 cites
- 0540US2010247450A1Use of erythropoietinEPOPLUS GMBH & CO KG·Filed 2010·Application pending·0 cites
- 0634US2013122523A1In vitro process for the quick determaination of a patient's status relating to infection with mycobacterium tuberculosisBAHLMANN FERDINAND HERMANN·Filed 2011·Application pending·0 cites
- 0733US2015309015A1Method for determining compatibility between a donor and a recipient by means of the flow cytometric detection of alloreactive t cellsLOPHIUS BIOSCIENCES GMBH·Filed 2013·Application pending·0 cites
- 0830US2015301047A1Method for recognition of a presence of an infection with cmvRED FLAG DIAGNOSTICS GMBH·Filed 2013·Application pending·0 cites
- 0930US2007161552A1Use of low-dosage erythropoietin for stimulation of endothelial progenitor cells, for organ regeneration and for slowing the progression of end-organ damageBAHLMANN FERDINAND H·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ferdinand Bahlmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →